Perbedaan Kasus Covid-19 pada Masa Lockdown dan  New Normal di Indonesia

Nugroho Susanto

doi:10.22146/jkesvo.62889

Perbedaan Kasus Covid-19 pada Masa Lockdown dan New Normal di Indonesia

https://doi.org/10.22146/jkesvo.62889

Nugroho Susanto^(1*)

(1) Fakultas Ilmu Kesehatan, Universitas Respati Yogyakarta
(*) Corresponding Author

Abstract

Latar Belakang: Pandemi COVID-19 berdampak pada peningkatan angka kesakitan dan kematian di sejumlah negara. Kasus terkonfirmasi COVID-19 yang tercatat 414.179 dengan 18.440 angka kematian (CFR 4,4%) dilaporkan di 192 negara. Adanya penerapan kebijakan lockdown pada Maret-Mei 2020 dan new normal di Juni 2020 berdampak pada perbedaan kasus di kedua periode tersebut.

Tujuan: Mengetahui perbedaan kasus terkonfirmasi, angka kematian, dan case fatality rate (CFR) COVID-19 antara masa lockdown dan new normal di Indonesia.

Metode: Penelitian kualitatif dengan pendekatan cross-sectional disertai telaah dokumen online. Penelitian ini mengidentifikasi kasus COVID-19 selama 156 hari yang dilaporkan oleh Kementerian Kesehatan RI melalui laman https://covid19.kemkes.go.id/. Pengumpulan data dilakukan dari Maret−Agustus 2020. Analisis data menggunakan uji independent t test dengan confidence interval 95% (α = 0,05)

Hasil: Rerata kasus terkonfirmasi dan kematian akibat COVID-19 lebih tinggi pada saat new normal dibanding saat lockdown, yaitu 338,6±213,1; 1483,7±485,7 dan 20,7±14,1; 58,9±21,9, sedangkan case fatalty rate lebih rendah pada new normal dibanding lockdown (0,04±0,01; 0,08±0,07). Terdapat perbedaan yang signifikan pada kasus terkonfirmasi (p = 0,000), angka kematian (p = 0,000), dan case fatalty rate COVID-19 (p = 0,000) antara masa pemberlakuan lockdown dan new normal.

Kesimpulan: Meskipun rerata kasus terkonfirmasi dan kematian lebih tinggi di masa new normal, rerata fatalitas kematiannya lebih rendah.

Keywords

COVID-19; New normal; Lockdown; Indonesia

Full Text:

PDF

References

Adnan, M. et al. (2020) ‘COVID-19 infection : Origin , transmission , and characteristics of human coronaviruses’, Journal of Advanced Research, 24, pp. 91–98. doi: 10.1016/j.jare.2020.03.005.

Ali, M. J. (2020) ‘ORIGINAL RESEARCH A Survey on the Impact of COVID-19 on Lacrimal Surgery : The Asia-Pacific Perspective’, pp. 3789–3799.

Bambra, C. et al. (2020) ‘The COVID-19 pandemic and health inequalities’, pp. 1–5. doi: 10.1136/jech-2020-214401.

Carlucci, L., Ambrosio, I. D. and Balsamo, M. (2020) ‘Demographic and Attitudinal Factors of Adherence to Quarantine Guidelines During COVID-19 : The Italian Model’, 11(October), pp. 1–13. doi: 10.3389/fpsyg.2020.559288.

Chan, J. F. et al. (2020) ‘A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster’, The Lancet, 395(10223), pp. 514–523. doi: 10.1016/S0140-6736(20)30154-9.

Chu, D. K. et al. (2020) ‘Articles Physical distancing , face masks , and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19 : a systematic review and meta-analysis’, pp. 1973–1987. doi: 10.1016/S0140-6736(20)31142-9.

Depkes RI (2020) ‘Analisis data covid-19 indonesia’.

Feleke, B. T., Wale, M. Z. and Yirsaw, M. T. (2021) ‘Knowledge , attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital ’, PLoS ONE, 16(7), pp. 1–15. doi: 10.1371/journal.pone.0251708.

Goldstein, J. R. and Lee, R. D. (2020) ‘Demographic perspectives on the mortality of COVID-19 and other epidemics’. doi: 10.1073/pnas.2006392117.

Kementerian Kesehatan Republik Indonesia (2020) ‘Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19)’, Germas, pp. 0–115. Available at: https://infeksiemerging.kemkes.go.id/download/REV-04_Pedoman_P2_COVID-19__27_Maret2020_TTD1.pdf [Diakses 11 Juni 2021].

Kumar, A. and Misra, A. (2020) ‘Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information ’, (January).

Lai, C. et al. (2020) ‘International Journal of Antimicrobial Agents Global epidemiology of coronavirus disease 2019 ( COVID-19 ): disease incidence , daily cumulative index , mortality , and their association with country healthcare resources and economic status’, International Journal of Antimicrobial Agents, 55(4), p. 105946. doi: 10.1016/j.ijantimicag.2020.105946.

Rhyan, C., Turner, A. and Miller, G. (2020) ‘Tracking the U . S . health sector : the impact of the COVID = 19 pandemic’, Business Economics, (0123456789). doi: 10.1057/s11369-020-00195-z.

Susanto, N. & F. A. (2018) ‘Zonasi Komplikasi Penyakit Diabetes di Wilayah Bencana’, Jurnal Formil (Forum Ilmiah) KesMas Respati, 3(2), pp. 143–149.

Tay, M. Z. et al. (2020) ‘The trinity of COVID-19: immunity, inflammation and intervention’, Nature Reviews Immunology, 20(6), pp. 363–374. doi: 10.1038/s41577-020-0311-8.

Tay, M. Z. et al. (no date) ‘The trinity of COVID-19: immunity, inflammation and intervention 1,2’. doi: 10.1038/s41577-020-0311-8.

Wang, M., Liu, F. and Zheng, M. (2020) ‘Air quality improvement from COVID-19 lockdown : evidence from China’, (2).

WHO (2020a) Coronavirus Disease Coronavirus Disease Coronavirus Disease Internal for SEARO Ikhtisar Kegiatan Situation World Health World Health Organization Organization.

WHO (2020b) ‘Coronavirus Disease Ikhtisar Kegiatan’, 19, pp. 1–13.

Ye, Q. et al. (2020) ‘Epidemiological analysis of COVID ‐ 19 and practical experience from China’, J Med Virol., (March), pp. 1–15. doi: 10.1002/jmv.25813.

DOI: https://doi.org/10.22146/jkesvo.62889